SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 22.67+0.1%Jan 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey W. Burke who wrote (874)1/29/1998 2:26:00 PM
From: David S.  Read Replies (1) of 5736
 
from your post #874:"The technology they are using,which has NOT
been proven to work, was developed several years ago. It wasn't accepted then and it
won't be now. I'm sure when it is compared to our FDA APPROVED device ours will
come out on top. As Darby put it,they(SPRX) put the "cart before the horse". Setting
up distributors for something that has not been proven too work buy the FDA
standards does not make sense, but thats not for us to worry about at this point. If and
when they ever receive FDA approval (1-2 yrs) then we can consider them our
competition." - These are statements from the CEO, Darby Simpson Macfarlane, we agree on that - yes? Unfortunately, we have a problem.
If you can successfully answer the questions I will pose, then you should feel better in being long the stock, if you cannot, then you will ask yourself, "has Darby lied to us"? Don't worry, I already know the answer. We can do this in a civil fashion - I will be respectful and hopefully you will, too - agreed? #1 - Regarding SpectRX - "The technology they are using,which has NOT
been proven to work, was developed several years ago. It wasn't accepted then and it
won't be now." - This statement needs clarification.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext